AbbVie Inc. against Eli Lilly and Company — live side-by-side technical comparison.
Prices as of 2026-11-06T21:01:45+00:00 UTC · updates daily
ABBV leads 4 of the 5 windows we measure — over 1 month ABBV is +7.3% and LLY +13.9%; over year to date ABBV is +27.5% and LLY +26.0%. The ABBV/LLY price ratio stands at 0.2151, below its 50-day average of 0.2244, and below the 200-day average of 0.2177. A ratio above its own average means ABBV is gaining on LLY; on this reading the recent edge belongs to LLY.
| ABBV | LLY | |
|---|---|---|
| Price | $291.31 | $1354.00 |
| 1 day | +1.1%lead | -0.8% |
| 5 days | -1.2%lead | -4.5% |
| 1 month | +7.3% | +13.9%lead |
| 6 months | +42.1%lead | +37.2% |
| Year to date | +27.5%lead | +26.0% |
| 52-week position | 90% of range | 84% of range |
| 52-week range | $190.75–$302.93 | $850.51–$1453.00 |
| vs 50-day average | above $271.95 | above $1214.25 |
| vs 200-day average | above $238.94 | above $1099.64 |
| RSI (14) | 59 | 66 |
| Next earnings | 2026-10-30 | 2026-10-29 |
ABBV trades at $291.31, above its 50-day average of $271.95, and above the 200-day at $238.94. It sits at 90% of its 52-week range ($190.75–$302.93); 14-day RSI is 59, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $294.89 (1.2% away) and the first support below is $275.00 (5.6% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
LLY trades at $1,354.00, above its 50-day average of $1,214.25, and above the 200-day at $1,099.64. It sits at 84% of its 52-week range ($850.51–$1,453.00); 14-day RSI is 66, in neutral territory; an average session moves it about 3.9%. For levels, the first level overhead is $1,400.00 (3.4% away) and the first support below is $1,350.00 (0.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
LLY is the more volatile of the two — an average session moves it 3.9% against 2.7% for ABBV, so an identical position size carries roughly 1.4× the daily risk.
The comparison turns on those levels: ABBV clearing $294.89 or losing $275.00; LLY clearing $1,400.00 or losing $1,350.00. Until one of them gives way, the relative reading above stands.